Walleye Capital LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $292,438 - $378,578	-7,300 Reduced 26.45%	20,300 $813,000
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $995,085 - $1.3 Million	27,300 Added 9100.0%	27,600 $1.32 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $251,662 - $299,454	-5,800 Reduced 95.08%	300 $15,000
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $219,450 - $268,641	5,700 Added 1425.0%	6,100 $276,000
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $312,570 - $389,970	-9,000 Reduced 95.74%	400 $16,000
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $198,122 - $243,080	5,900 Added 168.57%	9,400 $335,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $129,919 - $162,820	3,500 New	3,500 $132,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $336,960 - $513,540	-8,100 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $339,255 - $411,201	-6,300 Reduced 43.75%	8,100 $489,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $100,402 - $122,655	1,700 Added 13.39%	14,400 $863,000
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $633,318 - $878,628	10,200 Added 408.0%	12,700 $816,000
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $132,300 - $202,925	2,500 New	2,500 $203,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.